Below are two novel trials exploring conditions of the aorta that are currently enrolling at Baylor Scott & White – The Heart Hospital Plano. These trials leverage our multi-disciplinary team approach, which brings Cardiothoracic and Vascular surgeons together in our TAA clinic for collaborative, simultaneous visits with each patient. This approach has proven time and again to better inform decisions surrounding patient care plans and help produce stronger outcomes.
Technology is constantly evolving, and disruptive innovation is pushing the boundaries of cardiothoracic therapeutics. The growing acceptance of less invasive transcatheter interventions, for example, has made it one of the more explored surgical modalities. This progressive technology in cardiothoracic surgery was underscored in many sessions at this year’s meeting of The Society of Thoracic Surgeons (STS) in San Diego.
Outcomes from Partner 3, a clinical trial evaluating transcatheter aortic valve replacement, or TAVR, compared to traditional surgical repair for low risk patients with aortic stenosis were recently published in The New England Journal of Medicine.
Below are some of the latest updates from various Baylor University Medical Center, part of Baylor Scott & White Health, Graduate Medical Education (GME) programs over the last several months.
The Flame asks Laura Petrey, MD, FACS, program director of the Surgical Critical Care Fellowship at Baylor University Medical Center, part of Baylor Scott & White Health, and trauma surgeon on the medical staff, five questions about herself, her time teaching and the future of medicine.
